The present disclosure provides, inter alia, multi-drug Antibody Drug Conjugates (MD-ADCs) and Linking Assembly (LA) Units, that are constructed in a site-specific matter via ‘；orthogonal’； deprotection and drug loading. Also provided are, Protected Linking Assembly Units, which allow for ‘；orthogonal’； deprotection and construction of MD-ADCs and LA Units of the present disclosure.
